Navigation Links
Fujifilm's Aspire HD Receives FDA Clearance
Date:9/12/2011

STAMFORD, Conn., Sept. 12, 2011 /PRNewswire/ -- Breast Imaging facilities looking for increased diagnostic confidence in mammography screening can now benefit from the exceptional image quality of the Aspire™ HD Full Field Digital Mammography (FFDM) system from FUJIFILM Medical Systems U.S.A., Inc. Now FDA 510(k) cleared, the Aspire HD provides image clarity that enables extraordinary detail of potential abnormalities that not only assists in more accurate and reliable diagnoses, but also results in enhanced clinician productivity.

(Photo:  http://photos.prnewswire.com/prnh/20110316/NY65935)

The exceptional image quality of the Aspire HD is made possible in part by the system's unique proprietary detector that uses innovative dual layer amorphous selenium (a-Se) and the first use of Fujifilm's innovative Direct Optical Switching (DOS) technology. This new technology combined with the company's renowned 50-micron resolution provides facilities with the confidence they need for the detailed visualization that's required in mammography.

"Breast imaging facilities and their patients deserve the latest and most reliable technologies," says David Hotchkiss, Director, Product Marketing, Modality Solutions for Fujifilm. "As we build upon our proven technological foundation for mammography, Fujifilm will continue to provide exceptional image quality that will raise the bar for performance and reliability in breast screening."

The new DOS technology eliminates the use of Thin Film Transistors (TFTs) which are currently used in typical FFDM detector systems. By eliminating the TFTs, this new technology creates a direct image transfer that results in a higher efficiency image capture.  This process produces images with less noise and the potential to reduce dose, while delivering the performance and reliability digital mammography users have come to expect from Fujifilm.

Fujifilm is the world leader in FFDM with more than 8000 systems installed worldwide. The company was the first to bring computed radiography- (CR) based FFDM to the U.S. market in 2006 and has been successfully serving the needs of hospitals and imaging centers with the Aspire ClearView-CSm and the Aspire ClearView-1m, multi- and single-imaging plate systems with Image Intelligence™, Fujifilm's proprietary image processing technology.

"Now that Aspire HD has FDA clearance, Fujifilm is the first and only vendor to provide both CR-and DR-based FFDM systems in the U.S., assuring that we have a solution that is right for any and every facility's needs," concludes Hotchkiss. "The addition of the new DR based system to our product portfolio further establishes Fujifilm as an integrated x-ray room provider."

For more information about Fujifilm's Aspire HD FFDM system, please visit Aspire.fujimed.com.

About Fujifilm

FUJIFILM Medical Systems U.S.A., Inc. is a leading provider of diagnostic imaging products and medical informatics solutions to meet the needs of healthcare facilities today and well into the future. From a wide selection of digital x-ray systems, to the Synapse® brand of PACS, RIS and cardiovascular products, to advanced women's health imaging systems, Fujifilm has products that are ideal for any size imaging environment. FUJINON is a subsidiary of FUJIFILM Medical Systems U.S.A., Inc., and supplies technologically advanced endoscopes to the medical market. FUJIFILM Medical Systems U.S.A., Inc. is headquartered in Stamford, CT. For more information visit www.fujimed.com.  

FUJIFILM Holdings Corporation, Tokyo, Japan, brings continuous innovation and leading-edge products to a broad spectrum of industries, including electronic imaging, digital printing equipment, medical systems, life sciences, graphic arts, flat panel display materials, and office products, based on a vast portfolio of digital, optical, fine chemical and thin film coating technologies. The company was among the top 16 companies around the world granted U.S. patents in 2010, and in the year ended March 31, 2011, had global revenues of $25.8 billion*. Fujifilm is committed to environmental stewardship and good corporate citizenship. For more information, please visit www.fujifilmholdings.com.

* At an exchange rate of 86 yen to the dollar.

© 2011 FUJIFILM Medical Systems U.S.A., Inc.  


'/>"/>
SOURCE FUJIFILM Medical Systems U.S.A., Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Aspire Indiana Works with MedInformatix to Customize Practice Management and Electronic Medical Records Solution for Psychiatric Practices
2. Medivir Announces Positive 24-week Interim Data of TMC435 From the ASPIRE Study (C206)
3. ASPIRE Independent Review Board Announces 10 Ways to Protect Participants Rights in Clinical Drug Trials and Optimize Results From Research
4. Naviscan Receives CE Mark Approval for High-Resolution Breast PET and PET-Guided Biopsy
5. MedShape Solutions, Inc. Receives SBIR Phase I Development Grant for Shape Memory Meniscal Repair Device
6. NeuroSigma Receives Notice of Award from NIH for an STTR Grant for its Trigeminal Nerve Stimulation Therapy for Epilepsy
7. Mesoblast Receives Clearance to Begin First European Trial of Allogeneic or Off-The-Shelf Stem Cell Treatment for Heart Attacks
8. Lupin Receives Final Approval to Market Generic Ultram® ER
9. Assured Pharmacy, Inc. Receives Gross Proceeds of $400,000 from Sale of Convertible Debentures and Warrants
10. Masimo Pronto-7â„¢ Receives Japanese and Canadian Regulatory Clearances
11. Linagliptin Receives Approval in Europe for the Treatment of Type 2 Diabetes
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/26/2016)... June 27, 2016 Jazz Pharmaceuticals plc (Nasdaq: ... under the Hart-Scott-Rodino Antitrust Improvements Act of 1976, as ... Celator Pharmaceuticals, Inc. ("Celator"; Nasdaq: CPXX ) ... Daylight Time). As previously announced on May ... definitive merger agreement under which Jazz Pharmaceuticals has commenced ...
(Date:6/24/2016)... 24, 2016  Global Blood Therapeutics, Inc. (GBT) (NASDAQ: ... novel therapeutics for the treatment of grievous blood-based ... closing of its previously announced underwritten public offering ... public offering price of $18.75 per share. All ... by GBT. GBT estimates net proceeds from the ...
(Date:6/24/2016)... -- Dehaier Medical Systems Ltd. (NASDAQ: DHRM ... sells medical devices and wearable sleep respiratory products in ... agreement with Hongyuan Supply Chain Management Co., Ltd. (hereinafter ... 2016, to develop Dehaier,s new Internet medical technology business. ... leverage Hongyuan Supply Chain,s sales platform to reach Dehaier,s ...
Breaking Medicine Technology:
(Date:6/26/2016)... ... 26, 2016 , ... Pixel Film Studios Released ProSlice Levels, a Media Slicing ... their videos a whole new perspective by using the title layers in ProSlice ... , ProSlice Levels contains over 30 Different presets to choose from. FCPX ...
(Date:6/26/2016)... ... June 26, 2016 , ... ... they have been diagnosed with endometriosis. These women need a treatment plan to ... a comprehensive approach that can help for preservation of fertility and ultimately achieving ...
(Date:6/25/2016)... Miami, FL (PRWEB) , ... June 25, 2016 , ... The temporary closing of Bruton ... Plant City Observer , brings up a new, often overlooked aspect of head lice: ... The closing for fumigation is not a common occurrence, but a necessary one in the ...
(Date:6/25/2016)... ... , ... As a lifelong Southern Californian, Dr. Omkar Marathe earned his Bachelors ... Geffen School of Medicine at UCLA. He trained in Internal Medicine at Scripps Green ... hematology/oncology at the UCLA-Olive View-Cedars Sinai program where he had the opportunity to train ...
(Date:6/25/2016)... Montreal, Canada (PRWEB) , ... June 25, 2016 , ... ... the pursuit of success. In terms of the latter, setting the bar too high ... low, risk more than just slow progress toward their goal. , Research from ...
Breaking Medicine News(10 mins):